LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Lowering Intellia Therapeutics, Inc. (NTLA) Q3 19 Estimate To -0.61 From -0.43 8/2/2019 7:56:28 AM
  • Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $21 Price Target 8/2/2019 7:56:00 AM
  • Wedbush Raises Intellia Therapeutics, Inc. (NTLA) To Outperform From Neutral With $21 Up From $20 Price Target 5/3/2019 8:39:25 AM
  • Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY19 Estimate To -1.18 From -1.94 11/2/2018 6:31:35 AM
  • Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q4 19 Estimate To -0.48 From -0.52 11/2/2018 6:31:13 AM
  • Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q3 19 Estimate To -0.35 From -0.49 11/2/2018 6:30:56 AM
  • Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q2 19 Estimate To -0.54 From -0.56 11/2/2018 6:30:36 AM
  • Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q1 19 Estimate To -0.50 From -0.38 11/2/2018 6:30:17 AM
  • Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) FY18 Estimate To -1.89 From -2.00 11/2/2018 6:29:59 AM
  • Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) Q4 18 Estimate To -0.34 From -0.40 11/2/2018 6:29:42 AM
  • Wedbush Cuts Intellia Therapeutics, Inc. (NTLA) To Neutral From Outperform With $20 Down from $36 Price Target 11/2/2018 6:23:22 AM
  • Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY18 Rev. Estimate To 38.6 M From 33.5 M 8/2/2018 10:08:57 AM
  • Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) FY18 Estimate To -2.00 From -2.12 8/2/2018 10:08:35 AM
  • Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) Q3 18 Estimate To -0.57 From -0.62 8/2/2018 10:08:03 AM
  • Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $36 Price Target 5/18/2018 7:25:49 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap